GlassScriptPhysician profile
Larnie Booker
NPI 1730279563
$526.34
in general payments reported to CMS, 2019-2025
9 companies · $107 in 2025
The $107 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $14.11 · 2021: $27.19 · 2022: $87.03 · 2023: $66.61 · 2024: $122 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $146.97 | 2019-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Sanofi Pasteur INC. | $101.65 | 2019-2025 | |
| Corium, LLC | $76.94 | 2022-2024 | Azstarys |
| Pfizer INC. | $67.85 | 2019-2024 | |
| Kaleo, INC. | $57.33 | 2019-2023 | Auvi-Q |
| Glaxosmithkline, LLC. | $29.11 | 2020-2022 | |
| Phadia US INC. | $18.87 | 2025 | Immunocap |
| Seqirus USA INC | $16.22 | 2025 | Flucelvax |
| Welch Allyn | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larnie Booker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.